Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation

By Smallwood G.A.   Davis L.   Connor K.   Martinez E.   Stieber A.C.   Heffron T.G.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1476-1477

Elsevier

Access to resources Recommend Favorite

Hepatitis C treatment outcomes of African Americans following liver transplantation

By Smallwood G.A.   Coffey G.   Davis L.   Martinez E.   Stieber A.C.   Heffron T.G.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3317-3318

Elsevier

Access to resources Recommend Favorite

Recurrent Hepatitis C After Liver Transplantation

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Indication for mycophenolate mofetil therapy in hepatitis c patients undergoing liver transplantation

By Platz K.-P.   Mueller A.R.   Willimski C.   Mansoorian B.   Berg T.   Neuhaus R.   Hopf U.   Radke C.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2232-2233

Elsevier

Access to resources Recommend Favorite

Indications for Mycophenolate Mofetil Therapy in Hepatitis C-Patients Undergoing Liver Transplantation

By Platz K.P.   Mueller A.R.   Willimski C.   Mansoorian B.   Berg T.   Neuhaus R.   Hopf U.   Lobeck H.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1468-1469

Elsevier

Access to resources Recommend Favorite